speb/financial-data huggingface dataset:
PHI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 38402000000.00
PHI cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 177000000.00
PHI cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 20000000.00
PHI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 19041000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Share Issued: 219055775.00
PHI cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 100000000.00
PHI cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: 0.00
PHI income_statement (quarterly, 2025-09-30) — Special Income Charges: -984000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 120326000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 55474000000.00
PHI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -226733628.32
PHI income_statement (quarterly, 2025-09-30) — Tax Provision: 2083000000.00
PHI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
PHI cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -685000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Assets: 629556000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 400456000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Debt: 358291000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 121492000000.00
PHI income_statement (quarterly, 2025-09-30) — Total Expenses: 41373000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 508064000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 567611000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 344682000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 10029000000.00
PHI income_statement (quarterly, 2025-09-30) — Total Unusual Items: -984000000.00
PHI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -984000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 3000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 6505000000.00
PHI balance_sheet (quarterly, 2025-09-30) — Working Capital: -101437000000.00
PHI income_statement (quarterly, 2025-09-30) — Write Off: 984000000.00
PHI income_statement (annual, 2025-12-31) — +Operating Expense: 135276000000.00
PHI income_statement (quarterly, 2025-12-31) — +Operating Expense: 36587000000.00
PHI income_statement (annual, 2025-12-31) — +Total Revenue: 218388000000.00
PHI income_statement (quarterly, 2025-12-31) — +Total Revenue: 55105000000.00
PHI balance_sheet (annual, 2025-12-31) — Accounts Payable: 52570000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 52570000000.00
PHI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 31367000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 31367000000.00
PHI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -621324000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -621324000000.00
PHI balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 130204000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 130204000000.00
PHI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -18897000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -18897000000.00
PHI income_statement (annual, 2025-12-31) — Amortization: 8325000000.00
PHI cash_flow (annual, 2025-12-31) — Amortization Cash Flow: -1816000000.00
PHI cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: -1816000000.00
PHI income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 8325000000.00
PHI cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3962000000.00
PHI cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1111000000.00
PHI balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 6420000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 6420000000.00
PHI balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 3966000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3966000000.00
PHI income_statement (annual, 2025-12-31) — Basic Average Shares: 216482724.00
PHI income_statement (annual, 2025-12-31) — Basic EPS: 138.63
PHI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 10011000000.00
PHI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 10092000000.00
PHI balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 36547000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 36547000000.00
PHI cash_flow (annual, 2025-12-31) — Capital Expenditure: -63081000000.00
PHI cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -10988000000.00
PHI cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -2724000000.00
PHI cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -659000000.00
PHI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 64173000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 64173000000.00
PHI balance_sheet (annual, 2025-12-31) — Capital Stock: 1603000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1603000000.00
PHI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 11866000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 11866000000.00
PHI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 12235000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 12235000000.00
PHI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -20590000000.00
PHI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -14000000.00
PHI balance_sheet (annual, 2025-12-31) — Cash Equivalents: 1369000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 1369000000.00
PHI balance_sheet (annual, 2025-12-31) — Cash Financial: 10497000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Cash Financial: 10497000000.00
PHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -35927000000.00
PHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -9763000000.00
PHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -60979000000.00
PHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11395000000.00
PHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 98738000000.00
PHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 22973000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Account Payable: -7754000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -6875000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -9921000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -3391000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Inventory: 1742000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Inventory: 605000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 279000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 13000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 72000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 29000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -6250000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -177000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Payable: -7754000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Payable: -6875000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -17675000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -10266000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5739000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3892000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Receivables: -1787000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Receivables: -2711000000.00
PHI cash_flow (annual, 2025-12-31) — Change In Working Capital: -17880000000.00
PHI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -8615000000.00
PHI cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2052000000.00
PHI cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -2874000000.00
PHI cash_flow (annual, 2025-12-31) — Changes In Cash: 1832000000.00
PHI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1815000000.00
PHI balance_sheet (annual, 2025-12-31) — Common Stock: 1093000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Common Stock: 1093000000.00
PHI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 126379000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 126379000000.00
PHI balance_sheet (annual, 2025-12-31) — Construction In Progress: 68808000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 68808000000.00
PHI income_statement (annual, 2025-12-31) — Cost Of Revenue: 28794000000.00
PHI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6950000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 52916000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 52916000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Assets: 69413000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Assets: 69413000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 8897000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 8897000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Debt: 16180000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Debt: 16180000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 25077000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 25077000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 9445000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 9445000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 9445000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 9445000000.00
PHI balance_sheet (annual, 2025-12-31) — Current Liabilities: 159143000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 159143000000.00
PHI cash_flow (annual, 2025-12-31) — Depreciation: 59487000000.00
PHI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 59487000000.00
PHI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 17667000000.00
PHI income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 59487000000.00
PHI income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 17667000000.00
PHI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 59487000000.00
PHI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 17667000000.00
PHI income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 59487000000.00
PHI income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 17667000000.00
PHI income_statement (annual, 2025-12-31) — Depreciation Income Statement: 51162000000.00
PHI balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
PHI balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
PHI income_statement (annual, 2025-12-31) — Diluted Average Shares: 216482724.00
PHI income_statement (annual, 2025-12-31) — Diluted EPS: 138.63
PHI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 28603000000.00
PHI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3576000000.00
PHI balance_sheet (annual, 2025-12-31) — Dividends Payable: 2087000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 2087000000.00
PHI balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 250000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 250000000.00
PHI income_statement (annual, 2025-12-31) — EBIT: 55838000000.00
PHI income_statement (quarterly, 2025-12-31) — EBIT: 9673000000.00
PHI income_statement (annual, 2025-12-31) — EBITDA: 115325000000.00
PHI income_statement (quarterly, 2025-12-31) — EBITDA: 27340000000.00
PHI income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -428000000.00
PHI income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -740000000.00
PHI cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 428000000.00
PHI cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 741000000.00
PHI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 23000000.00
PHI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -41000000.00
PHI balance_sheet (annual, 2025-12-31) — Employee Benefits: 3810000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 3810000000.00
PHI cash_flow (annual, 2025-12-31) — End Cash Position: 11866000000.00
PHI cash_flow (quarterly, 2025-12-31) — End Cash Position: 11866000000.00
PHI balance_sheet (annual, 2025-12-31) — Financial Assets: 617000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Financial Assets: 617000000.00
PHI balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1030000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1030000000.00
PHI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -35927000000.00
PHI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -9763000000.00
PHI balance_sheet (annual, 2025-12-31) — Finished Goods: 740000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Finished Goods: 740000000.00
PHI cash_flow (annual, 2025-12-31) — Free Cash Flow: 35657000000.00
PHI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 11985000000.00
PHI cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 41000000.00
PHI cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 1452000000.00
PHI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -966000000.00
PHI cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 20000000.00
PHI income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 966000000.00
PHI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -20000000.00
PHI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -239000000.00
PHI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1545000000.00
PHI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -35733000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -35733000000.00
PHI income_statement (annual, 2025-12-31) — General And Administrative Expense: 34698000000.00
PHI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 8949000000.00
PHI balance_sheet (annual, 2025-12-31) — Goodwill: 62941000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Goodwill: 62941000000.00
PHI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 64421000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 64421000000.00
PHI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 50264000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 50264000000.00
PHI balance_sheet (annual, 2025-12-31) — Gross PPE: 998090000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 998090000000.00
PHI income_statement (annual, 2025-12-31) — Gross Profit: 189594000000.00
PHI income_statement (quarterly, 2025-12-31) — Gross Profit: 48155000000.00
PHI balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 203000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 203000000.00
PHI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
PHI income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
PHI balance_sheet (annual, 2025-12-31) — Income Tax Payable: 946000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 946000000.00
PHI income_statement (annual, 2025-12-31) — Insurance And Claims: 1402000000.00
PHI income_statement (quarterly, 2025-12-31) — Insurance And Claims: 348000000.00
PHI income_statement (annual, 2025-12-31) — Interest Expense: 18148000000.00
PHI income_statement (quarterly, 2025-12-31) — Interest Expense: 4701000000.00
PHI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 18148000000.00
PHI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 4701000000.00
PHI income_statement (annual, 2025-12-31) — Interest Income: 719000000.00
PHI income_statement (quarterly, 2025-12-31) — Interest Income: 168000000.00
PHI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 719000000.00
PHI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 168000000.00
PHI cash_flow (annual, 2025-12-31) — Interest Paid Cff: -13233000000.00
PHI cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -3803000000.00
PHI balance_sheet (annual, 2025-12-31) — Interest Payable: 2454000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Interest Payable: 2454000000.00
PHI cash_flow (annual, 2025-12-31) — Interest Received Cfi: 686000000.00
PHI cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 152000000.00
PHI balance_sheet (annual, 2025-12-31) — Inventory: 1843000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Inventory: 1843000000.00
PHI balance_sheet (annual, 2025-12-31) — Invested Capital: 421427000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 421427000000.00
PHI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -60979000000.00
PHI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11395000000.00
PHI balance_sheet (annual, 2025-12-31) — Investment Properties: 7789000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Investment Properties: 7789000000.00
PHI balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 4996000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 4996000000.00
PHI balance_sheet (annual, 2025-12-31) — Investments And Advances: 57421000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 57421000000.00
PHI balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 19151000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 19151000000.00
PHI balance_sheet (annual, 2025-12-31) — Investmentsin Joint Venturesat Cost: 33274000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Investmentsin Joint Venturesat Cost: 33274000000.00
PHI cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
PHI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 37472000000.00
PHI cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 3200000000.00
PHI balance_sheet (annual, 2025-12-31) — Land And Improvements: 61955000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 61955000000.00
PHI balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 55276000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 55276000000.00
PHI balance_sheet (annual, 2025-12-31) — Long Term Debt: 278868000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 278868000000.00
PHI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 334144000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 334144000000.00
PHI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 36150000000.00
PHI cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 3000000000.00
PHI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -38040000000.00
PHI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -9825000000.00
PHI balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 52425000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 52425000000.00
PHI balance_sheet (annual, 2025-12-31) — Long Term Provisions: 1836000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 1836000000.00
PHI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 813269000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 813269000000.00
PHI balance_sheet (annual, 2025-12-31) — Minority Interest: 1194000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Minority Interest: 1194000000.00
PHI income_statement (annual, 2025-12-31) — Minority Interests: -207000000.00
PHI income_statement (quarterly, 2025-12-31) — Minority Interests: -143000000.00
PHI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -11000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -427000000.00
PHI balance_sheet (annual, 2025-12-31) — Net Debt: 283182000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Net Debt: 283182000000.00
PHI cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 550000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 445000000.00
PHI income_statement (annual, 2025-12-31) — Net Income: 28662000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income: 3591000000.00
PHI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 28603000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3576000000.00
PHI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 28869000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3734000000.00
PHI income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
PHI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 28662000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3591000000.00
PHI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 28662000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3591000000.00
PHI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 37690000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 4972000000.00
PHI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 28869000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3734000000.00
PHI cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -217000000.00
PHI income_statement (annual, 2025-12-31) — Net Interest Income: -17449000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Interest Income: -4539000000.00
PHI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -393000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -869000000.00
PHI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1590000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -6625000000.00
PHI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1890000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -6825000000.00
PHI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -17449000000.00
PHI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -4539000000.00
PHI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -514000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 679000000.00
PHI cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 600000000.00
PHI balance_sheet (annual, 2025-12-31) — Net PPE: 376766000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Net PPE: 376766000000.00
PHI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -58920000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -9975000000.00
PHI cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
PHI cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 300000000.00
PHI cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 200000000.00
PHI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 62468000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 62468000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 333000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 333000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 1526000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 1526000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 11582000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 11582000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 6221000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 6221000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 6146000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 6146000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 11582000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 11582000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 75000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 75000000.00
PHI balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3810000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3810000000.00
PHI income_statement (annual, 2025-12-31) — Normalized EBITDA: 118568000000.00
PHI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 30023000000.00
PHI income_statement (annual, 2025-12-31) — Normalized Income: 31146005492.17
PHI income_statement (quarterly, 2025-12-31) — Normalized Income: 5605948109.41
PHI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 98738000000.00
PHI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 22973000000.00
PHI cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1487000000.00
PHI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 2964000000.00
PHI income_statement (annual, 2025-12-31) — Operating Income: 54318000000.00
PHI income_statement (quarterly, 2025-12-31) — Operating Income: 11568000000.00
PHI income_statement (annual, 2025-12-31) — Operating Revenue: 218388000000.00
PHI income_statement (quarterly, 2025-12-31) — Operating Revenue: 55105000000.00
PHI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 216055775.00
PHI balance_sheet (annual, 2025-12-31) — Other Current Assets: 16191000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 16191000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 16180000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 16180000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 4974000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 4974000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -35733000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -35733000000.00
PHI income_statement (annual, 2025-12-31) — Other Gand A: 9116000000.00
PHI income_statement (quarterly, 2025-12-31) — Other Gand A: 2677000000.00
PHI income_statement (annual, 2025-12-31) — Other Income Expense: 821000000.00
PHI income_statement (quarterly, 2025-12-31) — Other Income Expense: -2056000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1480000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1480000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Inventories: 224000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Inventories: 224000000.00
PHI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 16648000000.00
PHI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3873000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 46486000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 46486000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 65000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 65000000.00
PHI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 4492000000.00
PHI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 1367000000.00
PHI income_statement (annual, 2025-12-31) — Other Operating Expenses: 30849000000.00
PHI income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 7248000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Properties: 17511000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Properties: 17511000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Receivables: 1154000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1154000000.00
PHI balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 369000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 369000000.00
PHI income_statement (annual, 2025-12-31) — Other Taxes: 5328000000.00
PHI income_statement (quarterly, 2025-12-31) — Other Taxes: 1260000000.00
PHI balance_sheet (annual, 2025-12-31) — Payables: 61761000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Payables: 61761000000.00
PHI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 114677000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 114677000000.00
PHI cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 1434000000.00
PHI cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 306000000.00
PHI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4970000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4970000000.00
PHI balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 450000000.00
PHI balance_sheet (annual, 2025-12-31) — Preferred Stock: 510000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 510000000.00
PHI income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 59000000.00
PHI income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 15000000.00
PHI balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 510000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 510000000.00
PHI cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
PHI income_statement (annual, 2025-12-31) — Pretax Income: 37690000000.00
PHI income_statement (quarterly, 2025-12-31) — Pretax Income: 4972000000.00
PHI balance_sheet (annual, 2025-12-31) — Properties: 0.00
PHI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PHI cash_flow (annual, 2025-12-31) — Purchase Of Business: -186000000.00
PHI cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -2000000.00
PHI cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -217000000.00
PHI cash_flow (annual, 2025-12-31) — Purchase Of Investment: -544000000.00
PHI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -544000000.00
PHI cash_flow (annual, 2025-12-31) — Purchase Of PPE: -60140000000.00
PHI cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -10112000000.00
PHI balance_sheet (annual, 2025-12-31) — Raw Materials: 879000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Raw Materials: 879000000.00
PHI balance_sheet (annual, 2025-12-31) — Receivables: 32521000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Receivables: 32521000000.00
PHI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 28794000000.00
PHI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6950000000.00
PHI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 59487000000.00
PHI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 17667000000.00
PHI income_statement (annual, 2025-12-31) — Rent And Landing Fees: 1413000000.00
PHI income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 413000000.00
PHI income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 1413000000.00
PHI income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 413000000.00
PHI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -39062000000.00
PHI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -9825000000.00
PHI balance_sheet (annual, 2025-12-31) — Retained Earnings: 37320000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 37320000000.00
PHI income_statement (annual, 2025-12-31) — Salaries And Wages: 22767000000.00
PHI income_statement (quarterly, 2025-12-31) — Salaries And Wages: 5511000000.00
PHI cash_flow (annual, 2025-12-31) — Sale Of Business: 175000000.00
PHI cash_flow (quarterly, 2025-12-31) — Sale Of Business: -425000000.00
PHI cash_flow (annual, 2025-12-31) — Sale Of Investment: 151000000.00
PHI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: -325000000.00
PHI cash_flow (annual, 2025-12-31) — Sale Of PPE: 1220000000.00
PHI cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 137000000.00
PHI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 4914000000.00
PHI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1463000000.00
PHI income_statement (annual, 2025-12-31) — Selling General And Administration: 39612000000.00
PHI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 10412000000.00
PHI balance_sheet (annual, 2025-12-31) — Share Issued: 219055775.00
PHI balance_sheet (quarterly, 2025-12-31) — Share Issued: 219055775.00
PHI cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 1322000000.00
PHI cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 200000000.00
PHI cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -1022000000.00
PHI cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
PHI income_statement (annual, 2025-12-31) — Special Income Charges: -3004000000.00
PHI income_statement (quarterly, 2025-12-31) — Special Income Charges: -1138000000.00
PHI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 126889000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 126889000000.00
PHI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 61958000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 61958000000.00
PHI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -758994507.83
PHI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -668051890.59
PHI income_statement (annual, 2025-12-31) — Tax Provision: 8821000000.00
PHI income_statement (quarterly, 2025-12-31) — Tax Provision: 1238000000.00
PHI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
PHI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
PHI cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -2656000000.00
PHI cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: 1001000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Assets: 634828000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Assets: 634828000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Capitalization: 405757000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 405757000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Debt: 359221000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Debt: 359221000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 128083000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 128083000000.00
PHI income_statement (annual, 2025-12-31) — Total Expenses: 164070000000.00
PHI income_statement (quarterly, 2025-12-31) — Total Expenses: 43537000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 506745000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 506745000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 565415000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 565415000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 347602000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 347602000000.00
PHI income_statement (annual, 2025-12-31) — Total Other Finance Cost: 20000000.00
PHI income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 6000000.00
PHI balance_sheet (annual, 2025-12-31) — Total Tax Payable: 6854000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 6854000000.00
PHI income_statement (annual, 2025-12-31) — Total Unusual Items: -3243000000.00
PHI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -2683000000.00
PHI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -3243000000.00
PHI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -2683000000.00
PHI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 3000000.00
PHI balance_sheet (annual, 2025-12-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 6505000000.00
PHI balance_sheet (annual, 2025-12-31) — Working Capital: -89730000000.00
PHI balance_sheet (quarterly, 2025-12-31) — Working Capital: -89730000000.00
PHI income_statement (annual, 2025-12-31) — Write Off: 3970000000.00
PHI income_statement (quarterly, 2025-12-31) — Write Off: 1118000000.00
PHI income_statement (quarterly, 2026-03-31) — +Operating Expense: 32484000000.00
PHI income_statement (quarterly, 2026-03-31) — +Total Revenue: 56513000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 49183000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 32259000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -632666000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 130204000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -19700000000.00
PHI cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 828000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 6491000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 4048000000.00
PHI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 216056000.00
PHI income_statement (quarterly, 2026-03-31) — Basic EPS: 40.98
PHI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 11866000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 36802000000.00
PHI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -12388000000.00
PHI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -638000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 61836000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1603000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 14534000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15000000000.00
PHI cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -19000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 7256000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Cash Financial: 7278000000.00
PHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -8360000000.00
PHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11829000000.00
PHI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 22751000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -2436000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -592000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Inventory: -499000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 8000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -5000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -410000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Payable: -2436000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3028000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1532000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1358000000.00
PHI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -6824000000.00
PHI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1475000000.00
PHI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2562000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Common Stock: 1093000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 125411000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 71951000000.00
PHI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 9440000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 52576000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Assets: 74671000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 9679000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Debt: 29070000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 38749000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 8937000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 8937000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 179846000000.00
PHI cash_flow (quarterly, 2026-03-31) — Depreciation: 14280000000.00
PHI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 14280000000.00
PHI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 14280000000.00
PHI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 14280000000.00
PHI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 14280000000.00
PHI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 216056000.00
PHI income_statement (quarterly, 2026-03-31) — Diluted EPS: 40.98
PHI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8855000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 12008000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 268000000.00
PHI income_statement (quarterly, 2026-03-31) — EBIT: 15564000000.00
PHI income_statement (quarterly, 2026-03-31) — EBITDA: 29844000000.00
PHI income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 1023000000.00
PHI cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -1023000000.00
PHI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 106000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 3898000000.00
PHI cash_flow (quarterly, 2026-03-31) — End Cash Position: 14534000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Financial Assets: 688000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1036000000.00
PHI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -8360000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Finished Goods: 1250000000.00
PHI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 10363000000.00
PHI cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -472000000.00
PHI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -374000000.00
PHI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: 374000000.00
PHI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -793000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -41625000000.00
PHI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 8246000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Goodwill: 62941000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 64405000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 51959000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1007302000000.00
PHI income_statement (quarterly, 2026-03-31) — Gross Profit: 47073000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 434000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 1724000000.00
PHI income_statement (quarterly, 2026-03-31) — Insurance And Claims: 329000000.00
PHI income_statement (quarterly, 2026-03-31) — Interest Expense: 4307000000.00
PHI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 4307000000.00
PHI income_statement (quarterly, 2026-03-31) — Interest Income: 161000000.00
PHI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 161000000.00
PHI cash_flow (quarterly, 2026-03-31) — Interest Paid Cff: -3090000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Interest Payable: 2405000000.00
PHI cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 145000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Inventory: 2328000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 420873000000.00
PHI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11829000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Investment Properties: 8135000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 5084000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 58800000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 20184000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 33532000000.00
PHI cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 150000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 62617000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 52157000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 266392000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 318549000000.00
PHI cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 150000000.00
PHI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -5613000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 53716000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 1841000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 818311000000.00
PHI balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1247000000.00
PHI income_statement (quarterly, 2026-03-31) — Minority Interests: -49000000.00